Literature DB >> 15336536

Baculovirus-mediated expression and isolation of human ribosomal phosphoprotein P0 carrying a GST-tag in a functional state.

Yohichi Abo1, Akiko Hagiya, Takao Naganuma, Yukiko Tohkairin, Kunihiro Shiomi, Zenta Kajiura, Akira Hachimori, Toshio Uchiumi, Masao Nakagaki.   

Abstract

We constructed an overexpression system for human ribosomal phosphoprotein P0, together with P1 and P2, which is crucially important for translation. Genes for these proteins, fused with the glutathione S-transferase (GST)-tag at the N-terminus, were inserted into baculovirus and introduced to insect cells. The fusion proteins, but not the proteins without the tag, were efficiently expressed into cells as soluble forms. The fusion protein GST.P0 as well as GST.P1/GST.P2 was phosphorylated in cells as detected by incorporation of (32)P and reactivity with monoclonal anti-phosphoserine antibody. GST.P0 expressed in insect cells, but not the protein obtained in Escherichia coli, had the ability to form a complex with P1 and P2 proteins and to bind to 28S rRNA. Moreover, the GST.P0-P1-P2 complex participated in high eEF-2-dependent GTPase activity. Baculovirus expression systems appear to provide recombinant human P0 samples that can be used for studies on the structure and function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336536     DOI: 10.1016/j.bbrc.2004.07.196

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus.

Authors:  J L J Lin; V Dubljevic; M J Fritzler; Ban-Hock Toh
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

Review 2.  Towards a model of GCN2 activation.

Authors:  Glenn R Masson
Journal:  Biochem Soc Trans       Date:  2019-10-31       Impact factor: 5.407

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.